Patel Kinnari (CIK 1725929) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-22). Recent activity: Sell RCKT (767 shares), Sell RCKT (1,409 shares), Buy RCKT (21,099 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-22 | ROCKET PHARMACEUTICALS, INC. (RCKT) | President, Head of R&D and Chief Operating Officer | Sell | 767 | $4,947 |
| 2025-05-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | President, Head of R&D and Chief Operating Officer | Sell | 1,409 | $9,201 |
| 2025-04-10 | ROCKET PHARMACEUTICALS, INC. (RCKT) | President, Head of R&D and Chief Operating Officer | Buy | 21,099 | $99,165 |
来源：SEC Form 4 申报文件 · 截至 2025-05-22